AR003957A1 - PHARMACEUTICAL COMPOSITION TO TREAT A MAMMAL PATIENT SUFFERING FROM A PROGRESSIVE CHRONIC VASCULAR DISEASE (CPVD) - Google Patents
PHARMACEUTICAL COMPOSITION TO TREAT A MAMMAL PATIENT SUFFERING FROM A PROGRESSIVE CHRONIC VASCULAR DISEASE (CPVD)Info
- Publication number
- AR003957A1 AR003957A1 ARP960102973A AR10297396A AR003957A1 AR 003957 A1 AR003957 A1 AR 003957A1 AR P960102973 A ARP960102973 A AR P960102973A AR 10297396 A AR10297396 A AR 10297396A AR 003957 A1 AR003957 A1 AR 003957A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- cpvd
- vascular disease
- patient suffering
- treat
- Prior art date
Links
Abstract
Una composición farmacéutica útil para ser aplicada en un método de tratamiento de un paciente mamífero que padece una enfermedad vascularprogresiva crónica (CPVD) caracterizada por cicatrices y/o fibrosis, con el objeto de detener supro greso y causar la resolución de las lesionesexistentes. De acuerdo a dicho método, se le administra al paciente la composicion farmacéutica novedosa que contiene una cantidad efectiva depentosan polisulfato (PPS) o de una salfarmacéuticamen te aceptable del mismo. Se prefiere la vía oral de administración, oscilando la dosis diaria total dePPS o sal de PPS aproximadamente entre 50 y 1200 mg por día.A pharmaceutical composition useful to be applied in a method of treatment of a mammalian patient suffering from a chronic progressive vascular disease (CPVD) characterized by scarring and / or fibrosis, in order to stop its progression and cause the resolution of existing lesions. According to said method, the novel pharmaceutical composition containing an effective amount of pentosan polysulfate (PPS) or a pharmaceutically acceptable drug thereof is administered to the patient. The oral route of administration is preferred, with the total daily dose of PPS or PPS salt ranging from about 50 to 1200 mg per day.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/478,347 US5643892A (en) | 1995-06-07 | 1995-06-07 | Method of treating chronic progressive vascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003957A1 true AR003957A1 (en) | 1998-09-30 |
Family
ID=23899571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102973A AR003957A1 (en) | 1995-06-07 | 1996-06-06 | PHARMACEUTICAL COMPOSITION TO TREAT A MAMMAL PATIENT SUFFERING FROM A PROGRESSIVE CHRONIC VASCULAR DISEASE (CPVD) |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR003957A1 (en) |
AT (1) | ATE235908T1 (en) |
DE (1) | DE69627137T2 (en) |
DK (1) | DK0809505T3 (en) |
HK (1) | HK1005497A1 (en) |
PT (1) | PT809505E (en) |
RU (1) | RU2196589C2 (en) |
-
1996
- 1996-06-03 DK DK96917917T patent/DK0809505T3/en active
- 1996-06-03 PT PT96917917T patent/PT809505E/en unknown
- 1996-06-03 AT AT96917917T patent/ATE235908T1/en not_active IP Right Cessation
- 1996-06-03 DE DE69627137T patent/DE69627137T2/en not_active Expired - Fee Related
- 1996-06-03 RU RU97116166A patent/RU2196589C2/en not_active IP Right Cessation
- 1996-06-06 AR ARP960102973A patent/AR003957A1/en not_active Application Discontinuation
-
1998
- 1998-06-01 HK HK98104683A patent/HK1005497A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2196589C2 (en) | 2003-01-20 |
PT809505E (en) | 2003-08-29 |
DK0809505T3 (en) | 2003-07-07 |
DE69627137D1 (en) | 2003-05-08 |
ATE235908T1 (en) | 2003-04-15 |
DE69627137T2 (en) | 2003-12-04 |
HK1005497A1 (en) | 1999-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6713463B2 (en) | Methods and compositions for treating and preventing mucositis | |
ES2170069T3 (en) | 1-ALFA-HYDROXIPREVITAMINE D FOR ORAL ADMINISTRATION. | |
ES2188782T3 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACINE. | |
JP3623962B2 (en) | Pharmaceutical composition for intranasal administration of hydroxocobalamin | |
IT1245761B (en) | PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY. | |
IT1270594B (en) | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN | |
DE3789239T2 (en) | Pharmaceutical composition containing interferon for buccal administration. | |
RU94046316A (en) | Use of high effective phosphonates for preparing medicinal agents for osteoporosis treatment | |
ES2162615T3 (en) | METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION. | |
EA200000468A1 (en) | THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY | |
EP0296236A1 (en) | Nasal delivery of caffeine | |
KR930007441A (en) | medicine | |
EP0682521A4 (en) | Method of treating damaged mucosal and epithelial tissues with misoprostol. | |
KR920703041A (en) | Ingredients and methods used to treat inflammatory or allergic diseases with pain | |
KR970025615A (en) | Cancer metastasis inhibitor | |
ES2115571T3 (en) | USE OF PENTOSANA POLISULFATE FOR THE RESOLUTION OF SCARS IN CHRONIC PROGRESSIVE VASCULAR DISEASES. | |
MX9205568A (en) | PHARMACEUTICAL COMPOSITION CONTAINING AMOUNTS OF 5-AMINO-1BETA-D-RIBOFURANOSIL-IMIDAZOLE-4-CARBOXAMIDE. | |
AR035946A1 (en) | PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES | |
IT1244636B (en) | USE OF ACETYL L-CARNITINE IN THERAPEUTIC TREATMENT OF COMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT. | |
KR890006227A (en) | Phenol-containing antitussive liquid composition | |
AR008559A1 (en) | USE OF PENTOSANPOLISULFATE (PPS) OR OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | |
AR003957A1 (en) | PHARMACEUTICAL COMPOSITION TO TREAT A MAMMAL PATIENT SUFFERING FROM A PROGRESSIVE CHRONIC VASCULAR DISEASE (CPVD) | |
KR970005283A (en) | Use of sertraline to treat patients after myocardial infarction | |
RU2002129298A (en) | APPLICATION OF GALANTAMINE FOR THE TREATMENT OF PSYCHONEUROLOGICAL BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE | |
RU2003100081A (en) | METHODS AND COMPOSITIONS IN WHICH SULODEXIDE IS USED FOR THE TREATMENT OF DIABETIC NEPHROPATHY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |